CAMBRIDGE, Mass. & SINGAPORE, July 11, 2024--Sunbird Bio, a biotechnology company developing proprietary blood-based technologies to improve diagnosis and treatment of neurological disorders and ...

SUMMERLIN, Nev., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Secura Bio, Inc. (www.securabio.com), an integrated pharmaceutical company dedicated to the worldwide development and commercialization of ...

At the Society for Neuroscience annual meeting (SfN; 11–15 November 2023, Washington DC, USA), Ouyang presented a poster on developing a blood-based biomarker panel for the early screening and ...

/PRNewswire/ -- J INTS BIO announced the poster presentation of its novel, orally administered 4th generation EGFR-TKI 'JIN-A02' at the 2022 edition of the ...

Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024 Sep. 25, 2024 4:30 PM ET Cabaletta Bio, Inc. (CABA) ...

Sunbird Bio has unveiled new data demonstrating that its diagnostic technology classified Parkinson’s disease-positive blood samples with 86% accuracy through the direct detection of aggregated ...

Carlsbad, CA, Jan. 29, 2025-- Palisade Bio, Inc., a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune ...

Orca Bio’s T-cell immunotherapy candidate for blood cancers has more than doubled the number of patients surviving free of moderate-to-severe chronic graft versus host disease (GvHD). The Phase ...

Spear Bio Inc., a biotechnology company pioneering next-generation ultra-sensitive immunoassays, today announced that its pTau 217 blood test has been granted Breakthrough Device Designation by ...